Breast Adenocarcinoma Recruiting Phase 3 Trials for Cefotaxime (DB00493)

Also known as: Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Ca breast

IndicationStatusPhase
DBCOND0029215 (Breast Adenocarcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02488967Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerTreatment